Semaglutide Injection

Home / Semaglutide Injection






Semaglutide Injection | Apollo Endoscopy & Robotic Obesity Center


Apollo Endoscopy & Robotic Obesity Center

Semaglutide Injection

Obesity is a chronic metabolic disease that affects hormones regulating hunger, satiety, and insulin function. Modern medical science has introduced effective treatment options that go beyond dieting, and Semaglutide is one of the most widely discussed prescription therapies for weight management and type 2 diabetes control.

Semaglutide is not a cosmetic slimming drug. It is a scientifically studied metabolic therapy that must be prescribed and monitored by a specialist, with careful attention to eligibility, safety, and long-term metabolic strategy.

GLP-1 receptor agonist

Semaglutide works by mimicking a natural gut hormone involved in appetite and glucose regulation.

Once-weekly dosing

It is given as a once-weekly subcutaneous injection with dose escalation over time.

Long-term planning matters

Monitoring, nutrition, exercise, and realistic expectations are essential for durable results.

What Is Semaglutide?

Semaglutide belongs to a class of medications called GLP-1 receptor agonists. GLP-1, or Glucagon-Like Peptide-1, is a natural hormone released from the intestine after eating and plays a major role in regulating appetite, satiety, insulin secretion, blood sugar levels, and gastric emptying.

  • Appetite: helps regulate hunger intensity and food cravings.
  • Satiety: supports earlier fullness and smaller meal volumes.
  • Insulin secretion: improves insulin response in a glucose-sensitive way.
  • Blood sugar levels: helps smooth glucose spikes, especially in type 2 diabetes.
  • Gastric emptying: slows stomach emptying and reduces frequent hunger episodes.

Semaglutide mimics this hormone and enhances its natural effects in the body. It is administered as a once-weekly subcutaneous injection and should only be started after proper medical evaluation.

Semaglutide GLP-1 receptor agonist SatietyGlucoseInsulinAppetite

Semaglutide is a medical therapy for weight loss and metabolic control, not a cosmetic injection.

How Does Semaglutide Work?

Semaglutide promotes weight loss and metabolic improvement through several related mechanisms. These effects become most meaningful when paired with lifestyle modification and regular follow-up.

01

Appetite suppression

It acts on appetite centers in the brain, reducing hunger signals and cravings.

02

Increased satiety

Patients often feel full with smaller meal portions and better meal control.

03

Slower gastric emptying

Food remains longer in the stomach, reducing frequent hunger episodes.

04

Improved insulin sensitivity

It enhances insulin secretion and reduces blood sugar spikes, which is especially useful in type 2 diabetes.

These combined effects result in gradual, sustained weight reduction rather than abrupt short-term loss.

Who Can Be Prescribed Semaglutide?

Semaglutide may be considered in selected patients with obesity, overweight plus comorbidities, failed lifestyle therapy alone, or those preparing for bariatric surgery. It should only be prescribed after careful metabolic evaluation.

A

BMI >= 30 kg/m2

Appropriate for patients with clinical obesity after specialist review.

B

BMI >= 27 kg/m2 with comorbidities

This may include type 2 diabetes, hypertension, fatty liver disease, dyslipidemia, sleep apnea, and PCOS.

C

Failed lifestyle therapy alone

Can be considered when structured diet and exercise programs have not produced adequate results.

D

Preparing for bariatric surgery

Sometimes used to reduce surgical risk and help reduce liver size preoperatively.

Evaluation before starting Semaglutide

Before initiating therapy, a detailed clinical assessment is necessary.

  • Complete medical history
  • Weight and BMI calculation
  • Waist circumference measurement
  • Blood pressure assessment
  • Blood sugar including HbA1c and fasting glucose
  • Liver function tests

Medical evaluation also includes

  • Kidney function tests
  • Lipid profile
  • Thyroid function tests when indicated
  • History of pancreatitis
  • Family history of thyroid cancers
  • Screening for contraindications before treatment

Transform your life with Apollo Endoscopy & Robotic Obesity Centre.

If you are considering Semaglutide therapy, the right next step is structured consultation, clinical evaluation, and a long-term plan built around your obesity profile and metabolic goals.

Book Now

What Weight Loss Can Be Expected?

Clinical studies show average weight reduction of 5-10% in moderate doses and up to 10-15% in higher-dose regimens when there is good compliance. Results still vary from patient to patient.

5-10%

Typical weight reduction seen with moderate-dose treatment.

10-15%

Higher-dose regimens may produce stronger results with compliance.

Months

Weight loss is gradual and usually unfolds over several months.

Results depend on baseline BMI, lifestyle adherence, dose escalation, and individual metabolic response.

How Is Semaglutide Started?

Treatment is initiated at a low dose and gradually increased. This dose escalation helps reduce gastrointestinal side effects. Sudden high-dose initiation increases the risk of nausea and vomiting, so regular follow-up during dose adjustment is essential.

Common side effects

Most side effects are gastrointestinal and temporary, especially early in treatment.

  • Nausea
  • Vomiting
  • Bloating
  • Constipation
  • Diarrhea
  • Acid reflux
  • Reduced appetite

Less common but important

  • Gallstones, especially with rapid weight loss
  • Pancreatitis, which is rare but serious
  • Dehydration
  • Temporary hair thinning during rapid weight loss
  • Fatigue

Persistent or severe symptoms require medical review.

01

When Semaglutide should not be taken

Contraindicated in pregnancy or planned pregnancy, breastfeeding, personal or family history of medullary thyroid carcinoma, MEN type 2, history of severe pancreatitis, severe gastrointestinal motility disorders, or known hypersensitivity to the drug.

02

Gallbladder caution

Caution is advised in patients with gallbladder disease or concerning abdominal symptoms during treatment.

03

Monitoring while on Semaglutide

Monitoring includes weight tracking, blood sugar, HbA1c if diabetic, liver function, kidney function, blood pressure, and assessment of side effects.

04

Follow-up timing

Visits are usually scheduled every 4-8 weeks during initiation and periodically thereafter. Unsupervised long-term use is not recommended.

Important Precautions While on Treatment

Semaglutide works best when combined with stable hydration, protein-aware meals, exercise, and dependable follow-up. These supportive behaviors strongly influence safety and durability.

01

Maintain hydration

Adequate hydration reduces the risk of worsening nausea, vomiting-related dehydration, and poor tolerance.

02

Eat smaller, protein-rich meals

Smaller meals and adequate protein intake improve tolerance and support muscle preservation.

03

Avoid overeating despite reduced hunger

Overeating can worsen gastrointestinal symptoms even if appetite feels lower.

04

Limit alcohol and continue exercise

Alcohol should be limited, and regular exercise should continue to support long-term metabolic improvement.

05

Do not skip follow-up visits

Ongoing supervision is part of treatment, not an optional extra.

06

Persistent vomiting needs attention

If vomiting persists, dehydration risk increases and medical attention is needed.

Is Semaglutide a permanent solution?

Semaglutide helps control appetite while it is being taken.

  • Stopping the medication may lead to increased appetite
  • Weight regain is possible without sustained lifestyle modification
  • Obesity is a chronic disease and long-term strategy should be discussed before starting therapy

Can Semaglutide replace surgery?

For mild to moderate obesity, it may delay or avoid surgery in some patients.

  • For BMI >= 35-40, long-standing diabetes, or severe metabolic syndrome, bariatric or metabolic surgery may provide greater and more durable weight loss
  • Treatment choice must be individualized

When to seek urgent medical attention

Stop medication and seek medical help if any of the following develop. The live source repeats this section; it has been consolidated here into one clear block.

UrgentSevere abdominal pain radiating to the back
UrgentPersistent vomiting
UrgentSigns of pancreatitis
UrgentSevere dehydration
UrgentAllergic reaction or sudden severe weakness
Semaglutide is an effective and scientifically validated therapy for obesity and metabolic disease when prescribed appropriately. It is not a cosmetic injection, it requires proper medical evaluation, it needs ongoing monitoring, and it must be combined with lifestyle modification as part of a long-term metabolic strategy.

Starting the right treatment at the right time under specialist supervision improves safety and long-term success. Consultation with a GI, bariatric, and laparoscopic surgeon such as Dr. Naresh Singhi at Apollo Endoscopy & Robotic Obesity Center can help define the safest pathway for patients across Mumbai.

Book an Appointment

If you are considering Semaglutide injection for weight loss or metabolic control, schedule a consultation for clinical evaluation, treatment planning, and long-term supervision.

Talk to the clinic

Apollo Endoscopy & Robotic Obesity Center offers consultation for obesity care, metabolic therapy, endoscopic options, and bariatric surgery planning where required.

AddressG-37, 1st Floor, Hirnen Shopping Centre, S.V. Road, opposite Ratna Hotel, Goregaon West, Mumbai, Maharashtra 400062
DoctorsDr. Naresh M. Singhi
Dr. Anuj Naresh Singhi

This form block is styled and ready for the page. Hook it to the site's form system before publishing.

Visit Apollo Endoscopy Center

Use the map for location guidance, then contact the clinic to confirm consultation timing and whether medical therapy, endoscopic therapy, or surgery is the best fit for your case.

This page positions Semaglutide as part of a broader metabolic care pathway that may also involve nutrition support, exercise, monitoring, endoscopic intervention, or bariatric surgery depending on severity and long-term goals.